Previously, miR-362-5p was reported to represses neuroblastoma malignancy by targeting phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta (PI3K-C2β) [39]. The gene discussed is PIK3C2B; the disease is neuroblastoma.